Results 11 to 20 of about 27,995 (239)
Pregabalin Withdrawal in Patients Without Psychiatric Disorders Taking a Regular Dose of Pregabalin: A Case Series and Literature Review [PDF]
Neuropsychopharmacology Reports, 2021 Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or abuse, and little attention has been paid to patients who are prescribed
Masahiro Takeshima +2 more
exaly +3 more sources
Pregabalin use in forensic hospitals and prisons in German speaking countries—a survey study of physicians [PDF]
Frontiers in Public Health, 2023 BackgroundPregabalin is a gamma-aminobutyric acid (GABA) analog that was approved in the EU in 2004 for the treatment of neuropathic pain, generalized anxiety disorder and epilepsy.
Michal Novotny +11 more
doaj +3 more sources
Clinical use of pregabalin in the management of central neuropathic pain
Neuropsychiatric Disease and Treatment, 2007 Nanna B Finnerup, Troels S JensenDanish Pain Research Center, Department of Neurology, Aarhus University Hospital, Aarhus, DenmarkAbstract: Central neuropathic pain (central pain) is treated with antidepressants, various anticonvulsants, opioids, and ...
Nanna B Finnerup, Troels S Jensen
doaj +1 more source
Reactions Weekly, 2018 Pregabalin is a second-generation antiepileptic drug characterized by few antiepileptic indications, with a very good interaction profile in polytherapy. The therapeutic indications of pregabalin for the treatment of epileptic seizures have been largely overshadowed by its widespread use for the treatment of anxiety disorders (especially generalized ...
Andrea E. Cavanna
core +3 more sources
Pregabalin-induced first degree atrioventricular block in a young patient treated for pain from extrapulmonary tuberculosis [PDF]
, 2017 Pregabalin, widely used in the treatment of several pain disorders, is usually well tolerated. Uncommonly, the drug may induce cardiac side effects, rarely prolongation of the PR interval.
A Salzano (7706675) +11 more
core +6 more sources
Saudi Pharmaceutical Journal, 2023 Background: The Saudi Food and Drug Authority (SFDA) classified pregabalin as a controlled substance in 2018; however, whether this policy change has affected pregabalin use is unclear.
Ahmed Al-jedai +6 more
doaj +1 more source
BMJ Open, 2022 Objectives The objectives of this study were to investigate the utilisation patterns of pregabalin, to identify users potentially misusing pregabalin and to compare this group of patients to patients prescribed recommended doses of pregabalin concerning ...
Ronja Flemming
doaj +1 more source
Pregabalin abuse: a case report
Psychiatry and Clinical Psychopharmacology, 2021 Pregabalin is a gamma-amino butyric acid (GABA) analogue used in the treatment of epilepsy, neuropathic pain, and generalized anxiety disorder. Although pregabalin is not a controlled medication in Turkey, it has a potential risk of abuse.
Ilhan Yargic, Filiz Alyanak Ozdemiroglu
doaj +1 more source
PREGABALIN EFFECTS ON CELLULAR AND HUMORAL COMPONENTS OF BLOOD OF MICE (Mus musculus) [PDF]
Basrah Journal of Veterinary Research, 2017 The oral use of pregabalin was evaluated in this study to reveal its effects on some hematological and biochemical parameters of laboratory mice. The animals of this study were divided into three groups (twelve mice each).
Wissam Sajid Hashim Al-Uboody
doaj +1 more source
9-PREGABALIN EFFECTS ON CELLULAR AND HUMORAL COMPONENTS OF BLOOD OF MICE (Mus musculus) [PDF]
Basrah Journal of Veterinary Research, 2018 The oral use of pregabalin was evaluated in this study to reveal its effects on some hematological and biochemical parameters of laboratory mice. The animals of this study were divided into three groups (twelve mice each).
Wissam Sajid Hashim Al-Uboody
doaj +1 more source